Rebecca K. Soilson is a paralegal in Sterne Kessler’s Biotechnology & Chemical Practice Group, where she supports patent prosecution and patent office litigation.
Prior to joining Sterne Kessler, Rebecca interned in the Tanzi Lab at Massachusetts General Hospital’s Institute for Neurodegenerative Disease, where she conducted her senior thesis research related to Alzheimer’s disease. Specifically, Rebecca worked on the development of a novel therapeutic approach using magnetic nanoparticles to modulate one of the biological hallmarks of Alzheimer’s.
Rebecca received her B.A. cum laude from Harvard University, with high honors in her Neuroscience major and thesis and with a minor in Global Health and Health Policy.